Personal care composition

By using a combination of essential oils and organic acids, an alcohol-free personal care composition was prepared, solving the dryness and irritation problems of existing alcohol-based hand sanitizers. This resulted in a safe, gentle, and effective natural disinfection effect, particularly in reducing Staphylococcus aureus and Escherichia coli.

CN117715522BActive Publication Date: 2026-11-10COLGATE PALMOLIVE CO
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202280052112.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2021-08-03
Filing Date
2022-08-02
Publication Date
2026-11-10
Estimated Expiration
2042-08-02

AI Technical Summary

Technical Problem

Existing alcohol-based hand sanitizers tend to cause dry and irritated skin and require frequent use to maintain effectiveness, making it difficult to meet consumers' demand for safe, gentle, and effective natural sanitizers.

Method used

By combining essential oil systems and organic acids, including natural ingredients such as thymol and carvone, as active antibacterial agents, alcohol-free personal care compositions, such as hand sanitizers, are prepared. Combined with surfactants such as alkyl glucosides, they provide rapid and effective bacterial reduction.

Benefits of technology

Without the use of alcohol, the combination of essential oils and organic acids provides a powerful and rapid bacterial reduction effect, meeting the demand for safe, gentle and effective personal care products that reduce bacterial species such as Staphylococcus aureus and Escherichia coli.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004680939610000111
    Figure BDA0004680939610000111
  • Figure BDA0004680939610000121
    Figure BDA0004680939610000121
  • Figure BDA0004680939610000131
    Figure BDA0004680939610000131
Patent Text Reader

Abstract

Alcohol-free personal care compositions, such as hand sanitizers, are disclosed that effectively deposit locally active natural antibacterial compounds (e.g., carvone and thymol) onto the skin. In one aspect, this disclosure relates to personal care compositions comprising essential oils (e.g., thymol and carvone) combined with carboxylic acids (e.g., lactic acid) into an alcohol-free product, producing unexpected benefits against bacteria, such as reductions against Staphylococcus aureus and Escherichia coli.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] Cross-reference to related applications

[0002] This application is a U.S. non-provisional application claiming priority to Chinese Application No. 202110884865.9, filed on August 3, 2021, the contents of which are incorporated herein by reference in their entirety. Technical Field

[0003] This application relates to personal care compositions, in at least one aspect, alcohol-free personal care compositions (e.g., hand sanitizers); and methods for reducing local bacteria on the skin of an object. Background Technology

[0004] Personal hygiene, especially hand hygiene, receives significant attention. Effective hand cleaning may require washing hands or using hand sanitizer several times a day. Therefore, in most cases, hand sanitizer is the most convenient and effective way to clean hands. Currently, most hand sanitizers or sprays on the market are alcohol-based. Unfortunately, many alcohol-based sanitizers can cause dryness and are particularly likely to irritate the user's skin. Many hand sanitizers on the market need to be used multiple times a day to be effective. Therefore, the need to use hand sanitizer multiple times a day due to side effects such as dryness can be problematic for consumers who desire safer, gentler products that also provide effective antibacterial properties. However, developing natural, safe, and effective alcohol-free hand sanitizers is not without its challenges.

[0005] Therefore, there is a need in the market for alcohol-free natural hand sanitizers, such as foams or sprays, that are safe and effective without some of the potential drawbacks or negative properties common in many alcohol-based sanitizers. Summary of the Invention

[0006] This disclosure provides personal care compositions, such as hand sanitizers, comprising a combination of natural acids and plant essential oils as active antibacterial ingredients. The combinations described herein can unexpectedly provide strong and relatively rapid neutralization or reduction of a wide range of bacterial species without the use of alcohol-based substances. Furthermore, the active substances used in the formulations of this disclosure have the benefits of being naturally derived. The advantage of the high naturalness and safety of the personal care compositions of this disclosure lies in their ability to meet the market demand for effective personal care compositions that contain natural ingredients and are alcohol-free (e.g., hand sanitizers).

[0007] In one aspect, the present invention provides a personal care composition (e.g., a hand sanitizer) comprising an essential oil system and an organic acid, wherein the essential oil system comprises thymol and carvone, and wherein the organic acid comprises lactic acid. In yet other embodiments, the composition is free of any alcohol. In some embodiments, the composition is selected from: hand sanitizers, liquid soaps, liquid hand soaps, shower gels, body washes, shampoos, or conditioners.

[0008] In another aspect, the present invention provides a method for depositing a locally active compound onto the skin, the method comprising applying an effective amount of any of the personal care compositions disclosed herein to the skin.

[0009] In some embodiments, the composition comprises an alkyl glucoside as an auxiliary surfactant.

[0010] As will become apparent from the detailed embodiments provided below, further applications of this disclosure will become clear. It should be understood that while the detailed embodiments and specific examples indicate some typical aspects of this disclosure, they are for illustrative purposes only and are not intended to limit the scope of this disclosure. Detailed Implementation

[0011] The following descriptions of several typical aspects are merely exemplary in nature and are in no way intended to limit the content of this disclosure, its application, or its use.

[0012] As used throughout, a range is a shorthand for describing the individual values ​​within that range. Any value within the range can be chosen as an endpoint of the range.

[0013] Unless otherwise stated, all percentages and amounts expressed herein and elsewhere in this specification should be understood as weight percentages relative to the total composition. The amounts given are based on the effective weight of the substance.

[0014] This disclosure relates to alcohol-free personal care compositions that effectively deposit topical active natural antibacterial compounds (e.g., carvone and thymol) onto the skin. For example, it has been found that adding thymol and carvone (essential oils) in combination with lactic acid (carboxylic acid) to alcohol-free products produces unexpected benefits against bacteria, such as Staphylococcus aureus and Escherichia coli. Without being bound by theory, it is believed that alcohol-free compositions of this disclosure (e.g., alcohol-free hand sanitizers) can incorporate natural antibacterial ingredients and still exert the same effect as similar hand sanitizers using alcohol-based substances.

[0015] In one aspect, the present invention provides a personal care composition (composition 1.0), (e.g., a hand sanitizer), comprising:

[0016] • An effective amount of an essential oil system, wherein the essential oil system comprises essential oils selected from thymol, carvone, eugenol, carvacrol, tea tree oil, and combinations thereof; and

[0017] • A carboxylic acid source, wherein the carboxylic acid source comprises lactic acid and / or citric acid.

[0018] For example, this disclosure includes:

[0019] 1.1. The personal care composition of composition 1.0, wherein the essential oil system comprises: thymol and eugenol.

[0020] 1.2. Any of the aforementioned personal care compositions, wherein the essential oil system comprises: thymol and carvone.

[0021] 1.3. Any of the aforementioned personal care compositions, wherein the essential oil system comprises: thymol and carvacrol.

[0022] 1.4. Any of the aforementioned personal care compositions, wherein the essential oil system comprises: thymol and tea tree oil.

[0023] 1.5. Any of the aforementioned personal care compositions, wherein the essential oil system comprises tea tree oil and the carboxylic acid source comprises lactic acid.

[0024] 1.6. Any of the aforementioned personal care compositions, wherein the essential oil system comprises: thymol, carvone, and eugenol.

[0025] 1.7. Any of the aforementioned personal care compositions, wherein the essential oil system comprises: thymol, carvone, and tea tree oil.

[0026] 1.8. Any of the aforementioned personal care compositions, wherein the essential oil system comprises: thymol, carvone, and carvacrol.

[0027] 1.9. Any of the aforementioned personal care compositions, wherein the essential oil system comprises: thymol, carvone, eugenol, and tea tree oil.

[0028] 1.10. Any of the aforementioned personal care compositions, wherein the essential oil system comprises: thymol, carvone, carvacrol, eugenol, and tea tree oil.

[0029] 1.11. Any of the aforementioned personal care compositions, wherein the essential oil system further comprises essential oils selected from: limonene, pinene, camphene, cymene, citronellol, geraniol, nerol, linalool, terpineol, rose alcohol, borneol, isoborneol, menthone, camphor, safrole, isoflavone, menthol, geraniol, verbenone, eucalyptol, sennae, cedrol, anethole, cypermethrin, berberine, ferulic acid, cinnamic acid, methyl salicylic acid, methyl salicylate, terpineol, rosemary extract, tea extract, magnolia extract, menthol, eucalyptol, citral, catechin, epigallocatechin gallate, epigallocatechin gallate, gallic acid, miswak extract, sea buckthorn extract, isoeugenol, and combinations thereof.

[0030] 1.12. Any of the aforementioned personal care compositions, wherein the thymol is present in an amount of 0.05% to 2% by weight (e.g., 0.075% to 1% by weight) (e.g., about 0.1% by weight) of the total composition.

[0031] 1.13. Any of the aforementioned personal care compositions, wherein the carvone is present in an amount of 0.01% to 2% by weight (e.g., about 0.05% by weight) of the total composition.

[0032] 1.14. Any of the aforementioned personal care compositions, wherein the eugenol is present in an amount of 0.1% to 2% by weight (e.g., about 0.1% by weight) of the total composition.

[0033] 1.15. Any of the aforementioned personal care compositions, wherein the carvacrol is present in an amount of 0.01% to 2% by weight (e.g., about 0.05% by weight) of the total composition.

[0034] 1.16. Any of the aforementioned personal care compositions, wherein the tea tree oil is present in an amount of 0.1% to 2% by weight (e.g., about 0.3% by weight) of the total composition.

[0035] 1.17. Any of the aforementioned personal care compositions, wherein the essential oil system is present in an amount of 0.075% to 4% by weight (e.g., 0.075% to 0.2% by weight) (e.g., about 0.15% by weight) of the total composition.

[0036] 1.18. Any of the aforementioned personal care compositions, wherein the composition comprises one or more surfactants.

[0037] 1.19. Any of the aforementioned personal care compositions, wherein the surfactant comprises alkyl glucoside.

[0038] 1.20. Any of the foregoing personal care compositions, wherein the alkyl glucoside is present in an amount of 0.5% to 9% by weight of the composition, for example, 0.75% to 8%, 0.75% to 7%, or 0.75% to 6% by weight, and optionally wherein the alkyl glucoside is present in an amount of about 1% by weight of the composition.

[0039] 1.21. Any of the aforementioned personal care compositions, wherein the alkyl glucoside is C 8-25 Alkyl glucosides, for example, C 8-18 Alkyl glucoside, C 10-18 alkyl glucoside, or C 10-16 Alkyl glucoside, optionally wherein the alkyl glucoside is selected from decyl glucoside, octanoyl / octyl glucoside, lauryl glucoside, cocoyl glucoside, octyl glucoside, cetearyl glucoside, cetyl glucoside, hexadecyl glucoside, arachidonic glucoside, and combinations thereof.

[0040] 1.22. Any of the foregoing compositions, wherein the alkyl glucoside is decyl glucoside (e.g., about 1% by weight).

[0041] 1.23. Any of the aforementioned personal care compositions, wherein the surfactant comprises an effective amount of an amphoteric surfactant (e.g., betaine amphoteric surfactant) (e.g., cocamidopropyl betaine).

[0042] 1.24. Any of the aforementioned personal care compositions, wherein the zwitterionic surfactant is a betaine zwitterionic surfactant (e.g., 0.1% to 5% by weight of the total composition) (e.g., 0.5% to 4% by weight of the total composition) (e.g., about 3% by weight of the total composition).

[0043] 1.25. The aforementioned personal care composition, wherein the betaine zwitterionic surfactant is C8-C16 aminopropyl betaine (e.g., cocamidopropyl betaine).

[0044] 1.26. The aforementioned personal care composition, wherein the C8-C16 aminopropyl betaine is cocamidopropyl betaine.

[0045] 1.27. The aforementioned personal care composition, wherein the cocamidopropyl betaine is present in an amount of 0.5% to 4% by weight of the total composition.

[0046] 1.28. The aforementioned personal care composition, wherein the cocamidopropyl betaine is 1% to 4% by weight of the total composition.

[0047] 1.29. The aforementioned personal care composition, wherein the cocamidopropyl betaine is 1.5% to 3.5% by weight (e.g., about 3% by weight of the total composition).

[0048] 1.30. Any of the aforementioned personal care compositions, wherein the composition comprises cocamidopropyl betaine and decyl glucoside in a weight % ratio (e.g., weight %) of 3:1 to 0.5:1 (e.g., 1:1).

[0049] 1.31. Any of the aforementioned personal care compositions, wherein the total amount of surfactant present in the composition is from 0.5% to 5% by weight of the composition, for example, about 1% by weight.

[0050] 1.32. Any of the aforementioned personal care compositions, wherein the carboxylic acid source comprises lactic acid (e.g., 0.05% to 2% by weight of the composition).

[0051] 1.33. Any of the aforementioned personal care compositions, wherein the carboxylic acid source comprises citric acid (e.g., 0.05% to 2% by weight of the composition).

[0052] 1.34. Any of the aforementioned personal care compositions, wherein the carboxylic acid source further comprises glycolic acid, or acetic acid, or succinic acid, or fumaric acid, or a combination thereof.

[0053] 1.35. Any of the aforementioned personal care compositions, wherein the composition comprises a thickener.

[0054] 1.36. Any of the aforementioned personal care compositions, wherein the thickener comprises gum, optionally selected from xanthan gum, carrageenan, and combinations thereof.

[0055] 1.37. Any of the aforementioned personal care compositions, wherein the composition comprises a moisturizer, optionally wherein the moisturizer is selected from glycerin, sorbitol, xylitol, 1,3-propanediol, propylene glycol, polyethylene glycol, and combinations thereof.

[0056] 1.38. The aforementioned personal care composition, wherein the amount of surfactant in the composition is from 1% to 15% by weight of the total composition.

[0057] 1.39. Any of the aforementioned personal care compositions, wherein the composition comprises water (e.g., more than 70% by weight of the total composition) (e.g., 65% to 95% by weight of the total composition) (e.g., 65% to 85% by weight of the total composition) (e.g., 65% to 75% by weight of the total composition).

[0058] 1.40. Any of the aforementioned personal care compositions contains fragrance and / or colorant.

[0059] 1.41. Any of the aforementioned personal care compositions comprises an antimicrobial agent selected from: herbal extracts, biguanide preservatives (e.g., chlorhexidine, alexiconidine, or ostinidine), and quaternary ammonium compounds (e.g., hexadecylpyridine chloride). (CPC), benzalkonium chloride, tetradecylpyridine chloride (TPC), N-Tetradecyl-4-ethylpyridine chloride (TDEPC), phenolic preservatives, hexetine, ostinidine, sanguisorbin, povidone-iodine, dimopistol, salifluor, metal ions (e.g., zinc salts, zinc citrate; stannous salts; copper salts; iron salts), sanguisorbin, propolis, phthalic acid and its salts, monoperthalic acid and its salts and esters, ascorbic acid stearate, oleoylsarcosine, alkyl sulfates, dioctyl sulfosuccinate, salicylaniline, domiphen bromide, dimopistol, octopiol and other piperidinyl derivatives, nicin preparations, chlorites; and any mixtures of the foregoing.

[0060] 1.42. Any of the aforementioned personal care compositions contains an anti-inflammatory compound.

[0061] 1.43. Any of the aforementioned personal care compositions, wherein the composition is free of or substantially free of alcohol.

[0062] 1.44. Any of the aforementioned personal care compositions, wherein said composition (e.g., a hand sanitizer) comprises:

[0063] • Thymol (e.g., 0.05% to 2% by weight) (e.g., 0.1% by weight)

[0064] Eugenol (e.g., 0.05% to 2% by weight) (e.g., 0.1% by weight)

[0065] • Decyl glucoside (e.g., 0.05% to 2% by weight)

[0066] · 1,3-Propanediol (e.g., 0.5% to 4% by weight)

[0067] • Sorbitol (e.g., 0.5% to 6% by weight);

[0068] • Lactic acid (e.g., 0.05% to 2% by weight; and

[0069] ·water

[0070] 1.45. Any of the aforementioned personal care compositions, wherein said composition (e.g., a hand sanitizer) comprises:

[0071] • Thymol (e.g., 0.05% to 2% by weight) (e.g., 0.1% by weight)

[0072] • Carvacrol (e.g., 0.01% to 2% by weight) (e.g., 0.05% by weight)

[0073] • Decyl glucoside (e.g., 0.05% to 2% by weight)

[0074] · 1,3-Propanediol (e.g., 0.5% to 4% by weight)

[0075] • Sorbitol (e.g., 0.5% to 6% by weight)

[0076] • Glycerin (e.g., 0.05% to 2%)

[0077] • Xylitol (e.g., 0.5% to 4% by weight) (e.g., about 2% by weight);

[0078] • Lactic acid (e.g., 0.05% to 2% by weight)

[0079] ·water

[0080] 1.46. Any of the aforementioned personal care compositions, wherein said composition (e.g., a hand sanitizer) comprises:

[0081] • Thymol (e.g., 0.05% to 2% by weight) (e.g., 0.1% by weight)

[0082] • Carvone (e.g., 0.01% to 2% by weight) (e.g., 0.05% by weight)

[0083] • Decyl glucoside (e.g., 0.05% to 2% by weight)

[0084] · 1,3-Propanediol (e.g., 0.5% to 4% by weight)

[0085] • Sorbitol (e.g., 0.5% to 6% by weight)

[0086] • Glycerin (e.g., 0.05% to 2%)

[0087] • Xylitol (e.g., 0.5% to 4% by weight) (e.g., about 2% by weight);

[0088] • Lactic acid (e.g., 0.05% to 2% by weight)

[0089] ·water

[0090] 1.47. Any of the aforementioned personal care compositions, wherein said composition (e.g., a hand sanitizer) comprises:

[0091] • Tea tree oil (e.g., 0.1% to 0.5% by weight) (e.g., 0.3% by weight)

[0092] • Cocamidopropyl betaine (e.g., 0.1% to 2% by weight)

[0093] · 1,3-Propanediol (e.g., 0.5% to 4% by weight)

[0094] • Sorbitol (e.g., 0.5% to 6% by weight)

[0095] • Glycerin (e.g., 0.05% to 2%)

[0096] • Xylitol (e.g., 0.5% to 4% by weight);

[0097] • Lactic acid (e.g., 0.05% to 2% by weight) (e.g., 0.1% by weight)

[0098] ·water

[0099] 1.48. Any of the foregoing compositions, wherein the composition further comprises a gelling agent, an antioxidant, a fragrance, or a combination thereof.

[0100] 1.49. Any of the foregoing compositions, wherein the composition is selected from: hand sanitizers, liquid soaps, liquid hand soaps, shower gels, body washes, shampoos and conditioners.

[0101] 1.50. Any of the foregoing compositions, wherein the personal care composition is a hand sanitizer.

[0102] 1.51. Any of the foregoing compositions, wherein the pH of the composition is 3 to 5 (e.g., 3.25 to 4.25) (e.g., 3.5 to 4) (e.g., about 3.6) (e.g., about 3.95).

[0103] 1.52. Any of the foregoing compositions, wherein the composition effectively reduces the amount of Staphylococcus aureus and / or Escherichia coli.

[0104] 1.53. Any of the foregoing compositions, wherein the ratio (wt%) of thymol (%) to carvone (wt%) in the essential oil system is 5:1 to 1:5 (e.g., 2:1).

[0105] 1.54. Any of the foregoing compositions, wherein the ratio (wt%) of thymol (%) to eugenol (wt%) in the essential oil system is 5:1 to 1:5 (e.g., 1:1).

[0106] 1.55. Any of the foregoing compositions, wherein the ratio (wt%) of thymol (%) to carvacrol (wt%) in the essential oil system is 5:1 to 1:5 (e.g., 2:1).

[0107] 1.56. Any of the foregoing compositions, wherein the composition comprises thymol (e.g., about 0.1% by weight) and carvone (e.g., about 0.5% by weight), and citric acid or lactic acid, and wherein the composition reduces the Escherichia coli community by at least 95% (e.g., about 99%) after a contact of about 30 seconds or 60 seconds.

[0108] 1.57. Any of the foregoing compositions, wherein the composition comprises thymol (e.g., about 0.05% by weight), eugenol (e.g., about 0.05% by weight), lactic acid (e.g., about 0.1% by weight), and xylitol (e.g., about 2% by weight), and wherein the composition reduces the contacted Escherichia coli community by at least 85% (e.g., about 90%) after about 30 seconds.

[0109] 1.58. Any of the foregoing compositions, wherein the composition comprises thymol (e.g., about 0.05% by weight), eugenol (e.g., about 0.05% by weight), lactic acid (e.g., about 0.1% by weight), and xylitol (e.g., about 2% by weight), and wherein the composition reduces the contacted Escherichia coli community by at least 95% (e.g., about 99%) after about 60 seconds.

[0110] 1.59. Any of the foregoing compositions comprising thymol (e.g., 0.05% to 2% by weight) (e.g., 0.1% by weight) and eugenol (e.g., 0.05% to 2% by weight).

[0111] (e.g., 0.1% by weight) and lactic acid (e.g., 0.05% to 2% by weight).

[0112] 1.60. Any of the foregoing compositions comprises thymol (e.g., 0.05% to 2% by weight) (e.g., 0.1% by weight), carvacrol (e.g., 0.01% to 2% by weight) (e.g., 0.05% by weight) and lactic acid (e.g., 0.05% to 2% by weight).

[0113] 1.61. Any of the foregoing compositions comprises thymol (e.g., 0.05% to 2% by weight) (e.g., 0.1% by weight), carvone (e.g., 0.01% to 2% by weight) (e.g., 0.05% by weight) and lactic acid (e.g., 0.05% to 2% by weight).

[0114] 1.62. Any of the foregoing compositions, wherein the composition comprises 0.5% to 5% by weight of xylitol.

[0115] In another aspect, this disclosure provides personal care compositions, such as any of Composition 1.0, for reducing bacteria (e.g., Escherichia coli and / or Staphylococcus aureus) on the skin of an object.

[0116] In some aspects, this disclosure provides a method for reducing local bacteria on the skin of an object, said method comprising applying any of composition 1.0, etc., to the skin of the object.

[0117] In some aspects, this disclosure provides a method for reducing localized bacteria (e.g., Escherichia coli and / or Staphylococcus aureus) on the skin of an object, said method comprising applying any of composition 1.0, etc., to the skin of the object, wherein any of composition 1.0, etc., is applied to the skin to reduce the amount of bacteria Escherichia coli and / or Staphylococcus aureus. In some aspects, the application of a personal care composition (e.g., any of composition 1.0, etc.) is sustained for at least 30 seconds to achieve a reduction of at least 90% in the amount of Escherichia coli. In yet another aspect, the application of a personal care composition (e.g., any of composition 1.0, etc.) is sustained for at least 60 seconds to achieve a reduction of at least 95% in the amount of Escherichia coli.

[0118] In some embodiments, any of the compositions 1.0, etc., comprises an oil selected from the following: sunflower seed oil, olive oil, shea butter, jojoba oil, almond oil, grape seed oil, rosehip seed oil, mink oil, castor oil, soybean oil, mineral oil, and combinations thereof.

[0119] The compositions disclosed herein (e.g., any of Composition 1.0, etc.) can be any type of personal care composition. In some embodiments, the composition is any composition that can be formulated into a topical skin care preparation (e.g., a hand sanitizer) suitable for application to the skin. Examples of such personal care compositions include, but are not limited to: skin care compositions (e.g., hand sanitizers), antiperspirants, deodorants, body washes, creams, shower gels, bar soaps, shampoos, conditioners, and cosmetics. In some embodiments, the composition is a rinse-off product (liquid soap, liquid hand soap, shower gel, body wash, shampoo, or conditioner, etc.). The composition may comprise a single phase or may be a multiphase system, such as a system comprising a polar phase and an oil phase, optionally in the form of a stable emulsion. The composition may be liquid, semi-solid, or solid. The formulation can be provided in any suitable container, such as an aerosol can, tube or container with a porous cap, rollerball container, bottle, container with an open end, etc.

[0120] Water may be present in the composition. The water used to prepare the commercial personal care composition should be deionized and free of organic impurities. Water typically constitutes the balance of the composition and comprises about 10% to about 95% by weight, or about 10% to about 80% by weight, of the personal care composition. This amount of water includes added free water plus the amount introduced together with other substances such as glycerin, sorbitol, or any component of the present invention.

[0121] In some embodiments, this disclosure (e.g., any of Composition 1.0, etc.) also provides alcohol-free personal care formulations comprising moisturizers, antioxidants, pH adjusters, vitamins, fragrances, thickeners, oils, and water.

[0122] In some embodiments of this disclosure, lactic acid, sodium hydroxide, and citric acid can be used to adjust the pH of the composition.

[0123] In some embodiments, any of the compositions 1.0, etc., comprises one or more surfactants. Suitable surfactants may be zwitterionic or nonionic. In some embodiments, the surfactant may comprise alkyl glucosides. Alkyl glucosides are compounds produced by combining a sugar (e.g., glucose) with a fatty alcohol. Alkyl refers to an unbranched or branched carbon chain. In some embodiments, the alkyl group is unbranched. The alkyl group may be saturated or unsaturated. In some embodiments, the alkyl group is saturated. For example, any of the compositions 1.0, etc., may comprise decyl glucoside. The structure of decyl glucoside is shown below:

[0124]

[0125] Alkyl glucosides can be C 8-25 Alkyl glucosides, for example, C 8-18 Alkyl glucoside, C 10-18 alkyl glucoside, or C 10-16 Alkyl glucoside. In some embodiments, the alkyl glucoside is selected from decyl glucoside, octanoyl / octyl glucoside, lauryl glucoside, cocoyl glucoside, octyl glucoside, cetearyl glucoside, cetyl glucoside, hexadecyl glucoside, arachidonic glucoside, and combinations thereof. In some embodiments, the alkyl glucoside is selected from decyl glucoside, octanoyl / octyl glucoside, and combinations thereof. In some embodiments, the weight ratio of octanoyl / octyl glucoside to decyl glucoside in the composition is 2:1 or 4:1, for example, about 3:1. In some embodiments, the alkyl glucoside is present in an amount of 0.5% to 10% by weight of the composition.

[0126] In some embodiments, any of the compositions 1.0, etc., may contain a betaine zwitterionic surfactant, optionally also containing an alkyl glucoside. The betaine zwitterionic surfactant may be C8-C. 16 Aminopropyl betaine, for example, cocamidopropyl betaine. In some embodiments, the auxiliary surfactant may comprise a nonionic block copolymer, optionally also comprising an alkyl glucoside. The nonionic block copolymer may be a poly(propylene oxide) / poly(ethylene oxide) copolymer. In some embodiments, the copolymer has a polyoxypropylene molecular weight of 3000 g / mol to 5000 g / mol and a polyoxyethylene content of 60 mol% to 80 mol%. In some embodiments, the nonionic block copolymer is porrosalmer. In some embodiments, the nonionic block copolymer is selected from: porrosalmer 338, porrosalmer 407, porrosalmer 237, porrosalmer 217, porrosalmer 124, porrosalmer 184, porrosalmer 185, and combinations of two or more thereof. In some embodiments, the copolymer is porrosalmer 407. In some embodiments, the auxiliary surfactant may comprise a betaine zwitterionic surfactant and a nonionic block copolymer, optionally also comprising an alkyl glucoside.

[0127] In some embodiments, the personal care composition (e.g., any of Composition 1.0, etc.) may be free of or substantially free of sodium lauryl sulfate (SLS) and / or sodium lauryl ether sulfate (SLES). In some embodiments, the composition may be free of or substantially free of alkyl sulfates. In some embodiments, the alkyl sulfate is C 1-25 Alkyl sulfates, which may be saturated or unsaturated, and unbranched or branched. In some embodiments, the personal care composition may be free of or substantially free of alkyl aryl sulfonates, such as alkylbenzene sulfonates, such as sodium dodecylbenzene sulfonate. In some embodiments, the personal care composition may be free of or substantially free of alkyl sulfates and alkyl aryl sulfonates. In some embodiments, the composition may be free of or substantially free of sulfates.

[0128] As used herein, "personal care composition" means a product that can be applied to the skin or come into contact with a body surface during normal use to provide beneficial effects. A body surface includes skin, such as the dermis or mucous membranes. A body surface may also include structures associated with the body surface, such as hair, teeth, or nails. Examples of personal care compositions may include products applied to the human body to improve appearance, cleanliness, odor control, and / or general aesthetics.

[0129] As used herein, “substantially free of” a substance can refer to a composition in which the substance is present in an amount less than 0.1 wt%, less than 0.05 wt%, less than 0.01 wt%, less than 0.005 wt%, less than 0.001 wt%, or less than 0.0001 wt%, based on the total weight of the composition.

[0130] As used in this article, "carvone" refers to a compound that is a member of the terpenoid class and has the following structure:

[0131]

[0132] As used in this article, “carvone” can refer to R-(-)-carvone or S-(+)-carvone.

[0133] As used in this article, "thymol" can refer to 2-isopropyl-5-methylphenol, and specifically to p-cymene C 10 H 14 O is a natural monoterpene phenol derivative, isomeric with carvacrol, found in thyme oil and extracted from thyme (Thymus vulgaris). "Thymol" has the following structure:

[0134]

[0135] In some embodiments, the total amount of surfactant present in the personal care composition may be from 0.5% to 5% by weight of the composition, for example from 1% to 4% by weight, for example about 2% by weight.

[0136] When the surfactant systems disclosed in this disclosure are used in personal care compositions, such as skin care compositions, the surfactant systems increase the deposition of topical active compounds on the skin. Topical active compounds encompass a broad range of substances, including antibacterial agents, vitamins, pharmaceuticals, fragrance substances, antioxidants, antiperspirant active substances, deodorant active substances, and other skin care ingredients. In some embodiments, the personal care compositions of this disclosure contain vitamins. Exemplary vitamins may be, or may include, vitamin C, vitamin D, vitamin E, vitamin K, and combinations thereof. In some embodiments, the composition contains vitamin E, such as vitamin E acetate. In some embodiments, the vitamin may be present in amounts from 0.05% by weight to 1% by weight of the composition, for example, 0.05% by weight to 0.5% by weight, 0.05% by weight to 0.3% by weight, 0.05% by weight to 0.2% by weight, 0.05% by weight to 0.15% by weight, or about 0.1% by weight.

[0137] In some embodiments, the personal care compositions of the present invention may comprise: glycols, including propylene glycol, dipropylene glycol, tripropylene glycol, and mixtures thereof; glycerides, including monoglycerides, diglycerides, and triglycerides; medium- and long-chain organic acids, alcohols, and esters; surfactants, including emulsifiers and dispersants; amino acids, including glycine; structural agents, including thickeners and gelling agents, such as polymers, silicates, and silica; emollients; fragrances; and colorants, including dyes and pigments.

[0138] The personal care compositions of this disclosure (e.g., any of Composition 1.0, etc.) may contain an emollient in any desired amount to achieve a desired emollient effect. Emollients are known in the art and are used to impart a soothing effect to the skin. Non-volatile emollients are preferred. Categories of non-volatile emollients include non-silicone emollients and silicone emollients. Non-volatile non-silicone emollients include C 12-15Alkyl benzoate. Non-volatile organosilicon materials can be polyether siloxanes, polyalkylaryl siloxanes, or polyether siloxane copolymers. An exemplary non-volatile organosilicon material is phenyl trimethicone. Examples include, but are not limited to, PPG-14 butyl ether, PPG-3 myristyl ether, secondary alcohol ethoxylate, stearyl alcohol, stearic acid and its salts, glyceryl monoricinoleate, isobutyl palmitate, glyceryl monostearate, isochetyl stearate, sulfated tallow, oleyl alcohol, propylene glycol, isopropyl laurate, mink oil, sorbitan stearate, cetyl alcohol, hydrogenated castor oil, octadecyl stearate, hydrogenated soybean glyceryl ester, isopropyl isostearate, hexyl laurate, dimethyl brassinate, decyl oleate, diisopropyl adipate, dibutyl sebacate, diisopropyl sebacate, 2-ethylhexyl palmitate, isononyl isononanoate, isodecanyl isononanoate, isotriadecyl isononanoate, 2-ethylhexyl palmitate, 2-ethylhexyl stearate, di-(2-ethylhexyl)adip ... (Ethylhexyl) succinate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, octacosanol, butyl stearate, glyceryl monostearate, polyethylene glycol, oleic acid, triethylene glycol, lanolin, castor oil, sunflower seed oil, acetylated lanolin alcohol, acetylated lanolin, petrolatum, isopropyl lanolin, fatty acids, mineral oil, butyl myristate, isostearic acid, palmitic acid, PEG-23 oil ether, oleic acid ester, isopropyl linoleate, cetyl lactate, lauryl lactate, myristyl lactate, quaternized hydroxyalkyl aminoglucose ester, vegetable oil, isodecanyl oleate, isostearyl neopentanoate, myristyl myristate, oleyl ethoxymyristate, diethylene glycol stearate, ethylene glycol monostearate, myristyl stearate, isopropyl lanolinate, paraffin, glycyrrhizic acid, hydroxyethyl stearate amide. In some embodiments, the composition comprises oils selected from the group consisting of sunflower seed oil, olive oil, shea butter, jojoba oil, almond oil, grapeseed oil, rosehip seed oil, mink oil, castor oil, soybean oil, mineral oil, and combinations thereof. In some embodiments, the composition comprises sunflower seed oil.

[0139] The personal care compositions of this disclosure (such as any of Composition 1.0, etc.) may contain one or more humectants. Humectants can reduce evaporation and may also help preserve the composition by lowering its water activity, and may also impart a desired sweetness or flavor to the composition. Exemplary humectants may be, or may include, glycerin, propylene glycol, 1,3-propanediol, polyethylene glycol, sorbitol, xylitol, etc., or any mixture or combination thereof. In some embodiments, the humectant is selected from glycerin, xylitol, sorbitol, 1,3-propanediol, and combinations thereof.

[0140] In some embodiments, the personal composition (e.g., any of Composition 1.0, etc.) may contain a thickener. Exemplary thickeners may be, or may include, colloidal silica, pyrolytic silica, cross-linked polyvinylpyrrolidone (PVP) polymers, cross-linked polyvinylpyrrolidone (PVP), etc., or mixtures or combinations thereof. In some embodiments, the thickening system comprises a cross-linked polyvinylpyrrolidone (PVP) polymer. Exemplary thickeners may also be, or may include, carbomer (e.g., carboxyvinyl polymers), carrageenan (e.g., Irish moss, carrageenan, ι-carrageenan, etc.), high molecular weight polyethylene glycol, cellulose polymers, hydroxyethyl cellulose, carboxymethyl cellulose and their salts (e.g., sodium CMC), natural gums (e.g., black privet, xanthan gum, gum arabic, and tragacanth gum), colloidal magnesium aluminum silicate, etc., or mixtures or combinations thereof. In some embodiments, the thickener comprises or is a gum, optionally selected from xanthan gum, carrageenan, and combinations thereof.

[0141] In some embodiments, the personal care compositions of this disclosure (e.g., any of Composition 1.0, etc.) comprise one or more gelling agents. Examples of gelling agents include, but are not limited to, waxes, esters of fatty acids and fatty alcohols, triglycerides, partially or fully hydrogenated soybean oil, partially or fully hydrogenated castor oil, other partially or fully hydrogenated vegetable oils, stearyl alcohol, or other cosmetically acceptable substances, said gelling agent being solid or semi-solid at room temperature and providing a consistency suitable for application to the skin.

[0142] Antioxidants can be added to the composition, preferably as ingredient protectants and to maintain the long-term stability of the composition. Examples of antioxidants include, but are not limited to, citric acid, butylated hydroxytoluene, and pentaerythritol tetra-di-tert-butylhydroxyhydrocinnamate.

[0143] In some embodiments, the personal care compositions of this disclosure (e.g., any of Composition 1.0, etc.) comprise a polymeric substance for thickening, such as polyamide; a cellulose derivative (e.g., hydroxypropyl cellulose, hydroxypropyl methyl cellulose, etc.); and a natural or synthetic gum, such as polyglycerol esters, including agar, agarose, pectin, or guar gum; or mixtures or combinations thereof. A class of substances of interest for thickening an immiscible water phase includes derivatives of hydrolyzed starch or other polysaccharides, particularly esterified dextrins, such as dextrin palmitate. Another class of polymers particularly relevant to constructing an oil phase comprising an organosilicone oil includes polysiloxane elastomers. Suspending agents may also be used to thicken the liquid compositions according to the invention, such as silica or clays such as bentonite, montmorillonite, or lithium montmorillonite, including those available under the trademark Bentone. The compositions may be thickened with non-polymeric organic gelling agents, including selected dibenzyl sorbitols (e.g., dibenzyl sorbitol).

[0144] In some embodiments, the personal care compositions of this disclosure (e.g., any of Composition 1.0, etc.) contain fragrance. Any fragrance suitable for personal care purposes may be incorporated into the personal care compositions of the present invention. Fragrances are often relatively volatile aromatic compounds that are capable of entering the gas phase at skin surface temperatures.

[0145] The personal care compositions disclosed herein can be manufactured using methods known in the art. In one aspect, the ingredients are combined and optionally heated where melting of the components is required. The components are then mixed. In one aspect, a premixing process is included, in which essential oils are mixed with at least one surfactant and a moisturizer to ensure complete dissolution of the components in the oil phase. Desiredly, volatile substances, such as aromatic substances, are incorporated into the composition in the later stages of the mixing cycle to prevent their evaporation. After mixing, the composition can be poured directly into a dispenser and the container sealed to preserve the product until use.

[0146] In another aspect, the present invention provides a method for depositing a locally active compound onto the skin, the method comprising applying an effective amount of any of the personal care compositions disclosed herein (e.g., any of Composition 1, etc.) to the skin.

[0147] Example

[0148] Example 1

[0149] Determination of antibacterial efficacy

[0150] Four basic personal care preparations were prepared according to Table 1 below. Table 2 lists the antibacterial efficacy of the preparations in general detail.

[0151] Table 1. Formulations 1 to 4

[0152]

[0153]

[0154] Table 2 - Antibacterial and Antiviral Assays

[0155]

[0156] As shown in Table 2, formulations 1 through 4 demonstrated effective bacterial reduction against both Staphylococcus aureus and Escherichia coli after a contact time of 30 or 90 seconds. In a separate assay, formulation 1 also showed a 99.99% reduction in H1N1 virus after a 30-second contact time (data not shown in Table 2).

[0157] Example 2

[0158] The combination of carboxylic acids and essential oils provides improved antibacterial effects.

[0159] Table 3 - Formulations that modify the combination of thymol and carvone with lactic acid or citric acid

[0160]

[0161] Formulation samples (e.g., A through E listed in Table 3) demonstrate the improved benefits of combinations of essential oils such as thymol and carvone with citric acid or lactic acid. For example, formulation samples D and E, containing thymol and carvone as well as citric acid or lactic acid, unexpectedly improved E. coli reduction (both >99.999%) at both the 30-second (61.039%) and 60-second (95.027%) time points, compared to formulation sample C, which contains only thymol and carvone (and no lactic acid or citric acid). Similarly, formulation samples A and B—which contain only citric acid or lactic acid and no essential oils such as thymol and carvone—showed lower E. coli reductions at both the 30-second and 60-second time points compared to formulation samples C, D, and E.

[0162] Example 3

[0163] The amount of thymol affects its antibacterial efficacy against Escherichia coli.

[0164] Table 4 - Formulations with altered amounts (amount, % by weight) of thymol

[0165]

[0166] Formulation samples (e.g., D to F listed in Table 4) demonstrate the improvement benefit of the combination of both thymol and carvone with the combination of lactic acid (where the amount of thymol is 0.1% by weight). For example, when compared to samples containing thymol (0.05%) and carvone (0.5%) at both time points of 30 seconds (61.039%) and 60 seconds (95.027%), samples containing thymol (0.1%), carvone (0.05%), and lactic acid unexpectedly improved the reduction of E. coli at both time points of 30 seconds and 60 seconds (both reductions >99.999%). It should be noted that when comparing formulations D and E, despite the fact that the amount of thymol (0.05%) is consistent and carvone (0.05%) is added to formulation E, the reduction in E. coli is lower at the 30-second time point. Then, with the amount of thymol (0.1%) increased but all other ingredients kept the same, the reduction in E. coli in formulation F at the 30-second time point increased.

[0167] Example 4

[0168] Table 5 - Effect of pH on the antibacterial efficacy of the formulation against Escherichia coli (*Ingredients are listed as % by weight relative to the total composition)

[0169]

[0170]

[0171] By controlling the amounts of thymol, carvone, APG, xylitol, sorbitol, and 1,3-propanediol, Table 5 shows that the antibacterial efficacy of more alkaline formulations decreases once the pH is greater than 6.

[0172] Example 5

[0173] Table 6 – Including xylitol can enhance antibacterial efficacy in reducing E. coli.

[0174]

[0175] (*Ingredients are listed as a percentage by weight relative to the total composition)

[0176] By controlling the amounts of thymol and eugenol, as well as APG, xylitol, sorbitol, and 1,3-propanediol, Table 6 shows that the formulation containing xylitol exhibits greater antibacterial activity against Escherichia coli compared to similar formulations without xylitol.

[0177] Example 6

[0178] Representative formulations

[0179] In one aspect, Table 7 presents representative formulations of the hand sanitizers disclosed herein:

[0180] Table 7

[0181]

[0182] This disclosure has been described with reference to exemplary embodiments. Although a limited number of embodiments have been shown and described, those skilled in the art will understand that changes can be made to these embodiments without departing from the principles and spirit of the foregoing specific embodiments. This disclosure is intended to be construed as including all such modifications and variations, provided they fall within the scope of the appended claims or their equivalents.

Claims

1. A personal care composition comprising: a. An effective amount of an essential oil system, wherein the essential oil system comprises thymol, carvone, and optionally essential oils selected from eugenol, carvacrol, tea tree oil, and combinations thereof; and b. A carboxylic acid source, wherein the carboxylic acid source comprises lactic acid and / or citric acid.

2. The personal care composition according to claim 1, wherein the essential oil system comprises: thymol, carvone, and eugenol; thymol, carvone, and tea tree oil; thymol, carvone, and carvacrol; thymol, carvone, eugenol, and tea tree oil; or thymol, carvone, carvacrol, eugenol, and tea tree oil.

3. The personal care composition of claim 1, wherein the essential oil system comprises tea tree oil and the carboxylic acid source comprises lactic acid.

4. The personal care composition of claim 1, wherein the thymol is present in an amount of 0.05% to 2% by weight of the total composition.

5. The personal care composition of claim 1, wherein the essential oil system is present in an amount of 0.075% to 4% by weight of the total composition.

6. The personal care composition of claim 1, comprising a surfactant, wherein the surfactant comprises an alkyl glucoside, and / or wherein the carboxylic acid source comprises lactic acid.

7. The personal care composition of claim 6, wherein the alkyl glucoside, if present, is decyl glucoside.

8. The personal care composition of claim 7, wherein the lactic acid, if present, is present in 0.05% to 2% by weight of the composition.

9. The personal care composition of claim 1, wherein the composition comprises: i.) Thymol; ii.) Carvone; iii.) Decyl glucoside; iv.) 1,3-Propanediol; v.) Sorbitol; vi.) Glycerin; vii.) Xylitol; viii.) Lactic acid; and ix.) Water.

10. The personal care composition of claim 1, wherein the weight ratio of thymol to carvacrol in the essential oil system is from 5:1 to 1:

5.

11. The personal care composition of claim 1, wherein the pH of the composition is 3 to 5.

12. The personal care composition of claim 1, wherein the composition is selected from: hand sanitizers, liquid soaps, body washes, shampoos, and conditioners.

13. The personal care composition of claim 12, wherein the composition is a hand sanitizer.

14. The personal care composition of claim 12, wherein the composition is a liquid hand soap.

15. The personal care composition of claim 12, wherein the composition is a shower gel.

16. The personal care composition of claim 1, wherein the essential oil system is present in an amount of 0.075% to 0.2% by weight of the total composition.

17. The personal care composition of claim 1, wherein the essential oil system is present in an amount of 0.15% by weight of the total composition.

18. The personal care composition according to any one of claims 1 to 17, wherein the composition comprises thymol and carvone, and citric acid or lactic acid, and wherein the composition reduces the Escherichia coli community by at least 95% after 30 or 60 seconds of contact.

19. A method for reducing localized bacteria on the skin of an object, wherein the skin does not include wounds and sites of infection, wherein the method comprises applying a personal care composition according to any one of claims 1 to 18 to the skin of the object, and wherein the personal care composition reduces the amount of bacteria Escherichia coli and / or Staphylococcus aureus.

Citation Information

Patent Citations

  • Formulation comprising thymol useful in treatment of drug resistant bacterial infections

    CN1452491A

  • Botanical antimicrobial compositions

    US20140242198A1